tetano
Editor, Senior Moderator
Pathol Int
. 2022 Aug 30.
doi: 10.1111/pin.13267. Online ahead of print.
An autopsy case of fulminant myocarditis after severe acute respiratory syndrome coronavirus 2 vaccine inoculation
Hidetoshi Satomi[SUP] 1 2 [/SUP], Harutaka Katano[SUP] 3 [/SUP], Hiroyuki Kanno[SUP] 2 [/SUP], Mikiko Kobayashi[SUP] 2 [/SUP], Yukari Ohkuma[SUP] 4 [/SUP], Naoto Hashidume[SUP] 4 [/SUP], Tatsuya Usui[SUP] 4 [/SUP], Shunichi Tsukada[SUP] 5 [/SUP], Ichiro Ito[SUP] 1 [/SUP]
Affiliations
Abstract
A 61-year-old woman without significant medical history developed fever 3 days after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and went into shock the next day. She was negative for SARS-CoV-2 mRNA in real-time polymerase chain reaction (PCR). Finally, she died 10 days after vaccination. At autopsy, the heart showed moderate dilatation of both ventricles, and the myocardium showed an uneven color change and decreased elasticity. Histologically, severe myocarditis with extensive myocytolysis was observed. The myocarditis showed severe inflammatory cell infiltration with T-lymphocyte and macrophage predominance, and in addition to the inflammatory cells described above, vast nuclear dust accompanying neutrophilic infiltration was observed. In the bone marrow and lymph nodes, hemophagocytosis was observed. In postmortem examination, nucleic acids of any cardiotropic viruses including SARS-CoV-2 were not detected using multivirus real-time PCR system. We discussed the relationship between the possible immune reaction after vaccination and the myocarditis observed in this case from immunopathological viewpoints. This mRNA vaccine is the first applied nucleic acid vaccine for humans, and its mechanism of efficacy and immune acquisition remain unclear. We hope the accumulation of more detailed analyses of the similar cases to reveal the mechanism of this kind of adverse reaction.
Keywords: cytotoxic T-cells; hypercytokinemia; myocarditis; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination.
. 2022 Aug 30.
doi: 10.1111/pin.13267. Online ahead of print.
An autopsy case of fulminant myocarditis after severe acute respiratory syndrome coronavirus 2 vaccine inoculation
Hidetoshi Satomi[SUP] 1 2 [/SUP], Harutaka Katano[SUP] 3 [/SUP], Hiroyuki Kanno[SUP] 2 [/SUP], Mikiko Kobayashi[SUP] 2 [/SUP], Yukari Ohkuma[SUP] 4 [/SUP], Naoto Hashidume[SUP] 4 [/SUP], Tatsuya Usui[SUP] 4 [/SUP], Shunichi Tsukada[SUP] 5 [/SUP], Ichiro Ito[SUP] 1 [/SUP]
Affiliations
- PMID: 36040128
- DOI: 10.1111/pin.13267
Abstract
A 61-year-old woman without significant medical history developed fever 3 days after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and went into shock the next day. She was negative for SARS-CoV-2 mRNA in real-time polymerase chain reaction (PCR). Finally, she died 10 days after vaccination. At autopsy, the heart showed moderate dilatation of both ventricles, and the myocardium showed an uneven color change and decreased elasticity. Histologically, severe myocarditis with extensive myocytolysis was observed. The myocarditis showed severe inflammatory cell infiltration with T-lymphocyte and macrophage predominance, and in addition to the inflammatory cells described above, vast nuclear dust accompanying neutrophilic infiltration was observed. In the bone marrow and lymph nodes, hemophagocytosis was observed. In postmortem examination, nucleic acids of any cardiotropic viruses including SARS-CoV-2 were not detected using multivirus real-time PCR system. We discussed the relationship between the possible immune reaction after vaccination and the myocarditis observed in this case from immunopathological viewpoints. This mRNA vaccine is the first applied nucleic acid vaccine for humans, and its mechanism of efficacy and immune acquisition remain unclear. We hope the accumulation of more detailed analyses of the similar cases to reveal the mechanism of this kind of adverse reaction.
Keywords: cytotoxic T-cells; hypercytokinemia; myocarditis; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination.